sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks BMS-5

BMS-5

CAS No.:
1338247-35-0
Catalog Number:
AG009CM3
Molecular Formula:
C17H14Cl2F2N4OS
Molecular Weight:
431.2871
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$110
- +
5mg
99%
1 week
United States
$182
- +
10mg
99%
1 week
United States
$251
- +
25mg
99%
1 week
United States
$446
- +
50mg
99%
1 week
United States
$682
- +
100mg
99%
1 week
United States
$1098
- +
Product Description
Catalog Number:
AG009CM3
Chemical Name:
BMS-5
CAS Number:
1338247-35-0
Molecular Formula:
C17H14Cl2F2N4OS
Molecular Weight:
431.2871
MDL Number:
MFCD17019327
IUPAC Name:
N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide
InChI:
InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)
InChI Key:
IVUGBSGLHRJSSP-UHFFFAOYSA-N
SMILES:
O=C(C(C)C)Nc1ncc(s1)c1cc(nn1c1c(Cl)cccc1Cl)C(F)F
Properties
Complexity:
523  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
430.023g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
431.283g/mol
Monoisotopic Mass:
430.023g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
88A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.1  
Literature
Title Journal
Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3. British journal of pharmacology 20180601
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters 20130801
The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. The Journal of neuroscience : the official journal of the Society for Neuroscience 20120411
LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. The Journal of cell biology 20101004
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Molecular cancer therapeutics 20081101
Properties